Technology Knowledge Optimization for Type 1 Diabetes in Schools
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: TeKnO T1D curriculum.
- Who it may be relevant to
- Registry conditions: Type 1 Diabetes (T1D). Basic parameters: from 5 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Technology Knowledge Optimization for Type 1 Diabetes in Schools (TeKnO T1D: Schools): A Novel E-learning Platform for School Nurses to Advance Health Outcomes
Overview
The goal of this study is to evaluate the feasibility and acceptability of a school nurse focused e-Learning application to improve their diabetes device knowledge and confidence. School nurses will be asked to complete pre-/post-surveys around a 16-week curriculum.
Detailed description
The standard of care for pediatric type 1 diabetes (T1D) is the use of continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems to optimize glycemia. These diabetes technologies hold the potential to decrease the risk of acute and long-term complications. Yet, the rapid developments over the last decade have posed challenges for youth, caregivers, and healthcare professionals who must learn to use these devices. Use of these devices requires significant user interaction and remains labor-intensive, leading to variability in glycemic outcomes. Schools offer a unique opportunity to support these vulnerable populations. Youth with T1D spend nearly one third of their weekdays in school under the care of school nurses. School nurses have expressed a critical gap in their knowledge of T1D devices, which can negatively affect parent and student school experiences. To date, little to no research has explored interventions to support school nurses with T1D devices. Structured education may directly impact school nurse CGM and AID knowledge and confidence and student outcomes. e-Learning, defined as the delivery of education through digital resources, allows for flexible, asynchronous learning at a self-determined pace. App-based CGM and AID education stimulates active, problem-centered learning that improves the knowledge and confidence of endocrinology trainees. This study will adapt an existing diabetes technology e-Learning tool to meet the needs of school nurses. In earlier phases focus groups and user-centered design methods are used to adapt the TeKnO T1D curriculum. The TeKnO T1D: School app content will be pilot tested with school nurses in Pennsylvania to assess feasibility. The curriculum will be delivered to 36 school nurses over 16 weeks according to principles of spaced learning, which has been shown to optimize knowledge retention. Simultaneously, methods to collect health and school outcomes from the students of participating school nurses will be explored.
Interventions
- Other TeKnO T1D curriculum
The TeKnO T1D: School Intervention will be an e-Learning CGM and AID curriculum developed for nurses and delivered entirely through 20-25 multiple-choice questions developed from case-based scenarios reflecting real-world, school-based T1D management. After answering each question, participants receive immediate access to the correct answer, a comparison of their answer choice with that of their peers, and a detailed explanation of the correct answer choice. Participants receive 2 questions ever
Primary outcome measures
- Study Enrollment [Time frame: Baseline]
- Curriculum completion [Time frame: Primary endpoint (completion of 16 week curriculum)]
- Retention [Time frame: Primary endpoint (completion of 16 week curriculum)]
- Feasibility of Intervention Measure [Time frame: Primary endpoint (completion of 16 week curriculum)]
- Acceptability [Time frame: Primary endpoint (completion of 16 week curriculum)]
- Appropriateness [Time frame: Primary endpoint (completion 16 week curriculum)]
Secondary outcome measures (2)
- Device knowledge [Time frame: Baseline and primary endpoint (completion of 16 week curriculum)]
- Diabetes device confidence [Time frame: Baseline and primary endpoint (completion of 16 week curriculum)]
Eligibility criteria
Inclusion Criteria (School Nurses):
- Certified school nurse or obtaining certification
- Actively managing at least 1 student with type 1 diabetes ≤14 years of age who uses a diabetes device (CGM, insulin pump, or automated insulin delivery system)
- Employed in a school district in PA
- Equipped with a smartphone or device compatible with the app used to deliver curriculum
Inclusion Criteria (Parent-Child Dyads)
- Parent of a child diagnosed with T1D for ≥6 months
- Child ≤14 years of age and attends in-person school in Pennsylvania
- Child uses a CGM and/or AID system
Exclusion criteria
- Not able to participate in English (all)
- For School Nurses: No current work with in-person students (e.g., retired, cyber school only), not clinical school staff, prior participation in the study
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
United States · 1 center
- University of Pittsburgh — Pittsburgh
Identifiers
NCT: NCT07482488 · STUDY25070015 (Aim 3) · 1R21NR022207